Analyst Ratings for Akebia Therapeutics (AKBA)
AKBA Rating Summary
AKBA Price Target Summary
- Highest: $6.00 (H.C. Wainwright)
- Lowest: $1.00 (Leerink)
- Average: $3.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.67 (+274.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$3.67 (+274.1%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Leerink | Roanna Ruiz | Downgrade | Market Perform (Outperform) |
1.00 (N/A) |
0.95 (0.98) |
3.16% | Details |
| 6/4/2025 | H.C. Wainwright » Updated 8/6/2026 |
Matthew Caufield | New Coverage | Buy (N/A) |
6.00 (N/A) |
3.42 (0.98) |
-71.35% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
